Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Primary Immune Thrombocytopenia”

399 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 399 results

Not applicableNot Yet RecruitingNCT07146555
What this trial is testing

Vitamin D Satus in Adults With Newly Diagnosed ITP

Who this might be right for
Vitamin D Concentration
Assiut University 84
Large-scale testing (Phase 3)Study completedNCT01621204
What this trial is testing

A Trial of Eltrombopag or Intravenous Immune Globulin Before Surgery for Immune Thrombocytopenia Patients

Who this might be right for
Immune Thrombocytopenic Purpura
McMaster University 74
Not applicableEnded earlyNCT01386723
What this trial is testing

End of EXTEND: Discontinuation of Medication for Patients With Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenia
Weill Medical College of Cornell University 35
Large-scale testing (Phase 3)Ended earlyNCT04224688
What this trial is testing

Assess the Efficacy, Safety, and Tolerability of Rozanolixizumab in Adult Study Participants With Persistent or Chronic Primary Immune Thrombocytopenia (ITP)

Who this might be right for
Primary Immune Thrombocytopenia
UCB Biopharma SRL 30
Testing effectiveness (Phase 2)Looking for participantsNCT06838962
What this trial is testing

Anti-CD38 Antibody Treating Children With Primary Immune Thrombocytopenia (ITP)

Who this might be right for
Immune ThrombocytopeniaTreatment
Institute of Hematology & Blood Diseases Hospital, China 30
Early research (Phase 1)Looking for participantsNCT06371417
What this trial is testing

Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)

Who this might be right for
Antiphospholipid Syndrome (APS)Bullous Pemphigoid (BP)Behçet's Syndrome (BS)+3 more
Chugai Pharmaceutical 144
Not applicableNot Yet RecruitingNCT07182760
What this trial is testing

Ultrasound to Detect Splenomegally in Patients With Isolated Thrombocytopenia

Who this might be right for
Primary Immune Thrombocytopenic PurpuraAmegakaryocytic AplasiaUnilineage Myelodysplastic Syndrome ( Megakaryocyte Dysplasia)+2 more
Assiut University 100
Testing effectiveness (Phase 2)UnknownNCT04371939
What this trial is testing

Efficacy and Safety of Romiplostim Versus Eltrombopag in the Treatment of Thrombocytopenia in Patients With Wiskott-Aldrich Syndrome

Who this might be right for
Wiskott-Aldrich Syndrome
Federal Research Institute of Pediatric Hematology, Oncology and Immunology 30
Very early researchLooking for participantsNCT07174843
What this trial is testing

An Exploratory Study of CD19/CD22/BCMA CAR-T Cells (BZE2204) in Subjects With Relapsed or Refractory Autoimmune Diseases

Who this might be right for
Idiopathic Inflammatory Myopathies(IIM)Immune Thrombocytopenia(ITP)Systemic Lupus Erythematosus(SLE)
Shanghai Cell Therapy Group Co.,Ltd 20
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07196163
What this trial is testing

An Exploratory Study of Golidocitinib in Adult Patients With ITP

Who this might be right for
Immune Thrombocytopenia (ITP)
Peking University People's Hospital 138
Large-scale testing (Phase 3)Study completedNCT02279173
What this trial is testing

Long-term Study of Romiplostim in Thrombocytopenic Pediatric Patients With Immune Thrombocytopenia (ITP)

Who this might be right for
Immune Thrombocytopenia
Amgen 203
Not applicableLooking for participantsNCT06973356
What this trial is testing

Anti CD19/BCMA CAR Gene Therapy for Relapsed/Refractory Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenia (ITP)
Anhui Provincial Hospital 18
Testing effectiveness (Phase 2)Looking for participantsNCT06478537
What this trial is testing

TPO-RA Treatment on Immune Tolerance Induction of ITP Patients With Sustained Platelet Recovery After Treatment Termination

Who this might be right for
Immune Thrombocytopenia
Peking Union Medical College Hospital 56
Large-scale testing (Phase 3)Study completedNCT02391272
What this trial is testing

Study on Recombinant Human Thrombopoietin in Management of ITP in Pregnancy

Who this might be right for
Immune ThrombocytopeniaPregnancy
Shandong University 31
Testing effectiveness (Phase 2)WithdrawnNCT01976195
What this trial is testing

High-dose Dexamethasone Combining Thalidomide Versus Dexamethasone Mono-therapy for Management of Newly-diagnosed ITP

Who this might be right for
Immune Thrombocytopenia
Shandong University
Testing effectiveness (Phase 2)Study completedNCT04669600
What this trial is testing

A Phase 2a Study Evaluating BIVV020 in Adults With Persistent/Chronic Immune Thrombocytopenia (ITP)

Who this might be right for
Immune Thrombocytopenia (ITP)
Bioverativ, a Sanofi company 12
Post-approval studies (Phase 4)Looking for participantsNCT05522465
What this trial is testing

Short-course High-dose Prednisone and Dexamethasone in Children With ITP

Who this might be right for
Immune ThrombocytopeniaGlucocorticoidsChild, Only
Fujian Medical University Union Hospital 608
Not applicableUnknownNCT01101295
What this trial is testing

The ITP-RITUX Cohort: Rituximab in Immune ThrombocytoPenia.

Who this might be right for
Purpura, Thrombocytopenic, IdiopathicAutoimmune Thrombocytopenia
Henri Mondor University Hospital 250
Testing effectiveness (Phase 2)UnknownNCT05411874
What this trial is testing

Randomized Open-label Study of Chidamide Plus HD-DEX Versus HD-DEX in ITP

Who this might be right for
Thrombocytopenia
Shandong University 100
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05369364
What this trial is testing

The Combination of Zanubrutinib and High-dose Dexamethasone as First-line Treatment in Adult Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenia
Peking University People's Hospital 150
Load More Results